Stockscreener 앱 받기
2.38
3.64%
-0.09
시간 외 거래:
2.35
-0.03
-1.26%
전일 마감가:
$2.47
열려 있는:
$2.5
하루 거래량:
89,109
Relative Volume:
0.53
시가총액:
$22.07M
수익:
$14.58M
순이익/손실:
$-12.57M
주가수익비율:
-0.419
EPS:
-5.68
순현금흐름:
$-13.07M
1주 성능:
+15.53%
1개월 성능:
+14.98%
6개월 성능:
-46.28%
1년 성능:
-43.87%
1일 변동 폭
$2.36
$2.5399
1주일 범위
$2.0101
$2.69
52주 변동 폭
$1.925
$7.95
비보스 테라퓨틱스 Stock (VVOS) Company Profile
명칭
Vivos Therapeutics Inc
전화
(866)908-4867
주소
7921 SOUTHPARK PLAZA,, LITTLETON
VVOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
2.38 | 22.91M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
비보스 테라퓨틱스 주식(VVOS)의 최신 뉴스
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Is Vivos Therapeutics Inc a good long term investmentProtective Put Strategies & Ride the Trends That Billionaires Follow - earlytimes.in
Vivos Therapeutics (NASDAQ:VVOS) Trading Up 24.6% – What’s Next? - Defense World
Aug Breakouts: Why retail investors favor Vivos Therapeutics Inc stock2025 AllTime Highs & Capital Protection Trade Alerts - moha.gov.vn
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
VVOS SEC FilingsVivos Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Vivos Inc Summarizes Progress in its Animal Therapy Division - GlobeNewswire
Cancer-fighting pet therapy soars 1,200% as more vets join in 2025 - Stock Titan
A new cancer treatment for pets is quietly spreading across U.S. clinics - Stock Titan
Buyout Rumor: What dividend safety score for Vivos Therapeutics Inc. stockFed Meeting & Free Fast Entry Momentum Trade Alerts - Улправда
Will Vivos Therapeutics Inc. stock see insider buyingRecession Risk & Safe Capital Growth Trade Ideas - Улправда
ETF Watch: What dividend safety score for Vivos Therapeutics Inc. stockJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда
Is Vivos Therapeutics Inc. stock a safe buy before earningsJuly 2025 EndofMonth & Long-Term Safe Return Strategies - Улправда
Is Vivos Therapeutics Inc. stock a buy in volatile marketsJuly 2025 News Drivers & Technical Pattern Based Buy Signals - DonanımHaber
Is Vivos Therapeutics Inc. stock a safe investment in uncertain marketsPortfolio Risk Summary & Low Risk Investment Opportunities - DonanımHaber
Why Vivos Therapeutics Inc. stock is popular among millennialsWeekly Profit Summary & Stepwise Trade Signal Guides - Bölüm Sonu Canavarı
Published on: 2025-12-19 13:18:12 - DonanımHaber
Signal Recap: Is Vivos Therapeutics Inc. stock a safe buy before earningsJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - Улправда
Stop Loss: How Vivos Therapeutics Inc. stock compares to industry benchmarksAnalyst Upgrade & Free Weekly Chart Analysis and Trade Guides - Улправда
How Vivos Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - Улправда
Vivos Therapeutics Opens Affiliated Sleep Center in Michigan - Sleep Review
Vivos Therapeutics, Inc. Announces Grand Opening of Sleep Center in Michigan - TradingView — Track All Markets
Vivos opens new sleep center in Michigan, expanding national footprint By Investing.com - Investing.com Nigeria
Vivos opens new sleep center in Michigan, expanding national footprint - Investing.com India
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan - The Manila Times
Vivos Therapeutics (NASDAQ: VVOS) expands with MISleep-linked Detroit sleep center - Stock Titan
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST - The Manila Times
Vivos Therapeutics, Inc. CEO and CFO Set to Discuss Strategic Business Model and Market Opportunities in Upcoming Fireside Chat - Quiver Quantitative
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST - GlobeNewswire Inc.
Vivos Therapeutics (NASDAQ: VVOS) to discuss strategy in Water Tower fireside chat - Stock Titan
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Vivos Therapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Use Our Sector Rotation Strategy for Gains - earlytimes.in
What analysts say about Vivos Therapeutics Inc stockPrice Momentum Alerts & What the Pros Are Saying About This Stock - earlytimes.in
Vivos Therapeutics secures $2M note with Avondale - MSN
Vivos Therapeutics Secures $2M Note with Avondale - The Globe and Mail
Vivos Therapeutics, Inc. Enters into a Note Purchase Agreement with Avondale Capital, LLC - marketscreener.com
Can Vivos Therapeutics Inc. stock beat analyst upgradesJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser
Is Vivos Therapeutics Inc. stock a buy for dividend growthEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - Newser
Vivos Therapeutics, Inc. announced that it has received $2.09334 million in funding from Avondale Capital, LP - marketscreener.com
Vivos Therapeutics (NASDAQ:VVOS) Given New $5.50 Price Target at Ascendiant Capital Markets - Defense World
Is Vivos Therapeutics Inc. stock a smart buy before Fed meeting2025 Price Momentum & AI Enhanced Trading Alerts - Newser
VVOS: Ascendiant Capital Maintains Buy Rating, Lowers Price Targ - GuruFocus
Ascendiant Capital Maintains Vivos Therapeutics (VVOS) Buy Recommendation - Nasdaq
Vivos Therapeutics (VVOS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Vivos Therapeutics Reports Strong Q3 Growth Amid Challenges - MSN
Vivos Therapeutics Inc (VVOS) Q3 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ... By GuruFocus - Investing.com Canada
Why Vivos Therapeutics Inc. stock remains on buy lists2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q3 2025 Earnings Call Transcript - Insider Monkey
비보스 테라퓨틱스 (VVOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):